Plasma Genotyping at the Time of Diagnostic Tissue Biopsy Decreases Time-to-Treatment in Patients With Advanced NSCLC—Results From a Prospective Pilot Study by Jeffrey C. Thompson, MD, MTR, Charu Aggarwal, MD, MPH, Janeline Wong, BS, Vivek Nimgaonkar, BS, Wei-Ting Hwang, PhD, Michelle Andronov, BS, David M. Dibardino, MD, Christoph T. Hutchinson, MD, MA, Kevin C. Ma, MD, Anthony Lanfranco, MD, MS, Edmund Moon, MD, Andrew R. Haas, MD, PhD, Aditi P. Singh, MD, Christine A. Ciunci, MD, MSCE, Melina Marmarelis, MD, MSCE, Christopher D’Avella, MD, Justine V. Cohen, DO, Joshua M. Bauml, MD, Roger B. Cohen, MD, Corey J. Langer, MD, Anil Vachani, MD, MSCE, Erica L. Carpenter, MBA, PhD

Get full text